{
    "laboratory_examinations": [
        {
            "procedure_name": "Gel electrophoresis for SHOX mutation analysis",
            "date": "Not specified",
            "findings": "No mutations were detected by single-strand conformational polymorphism analysis of the PCR-amplified SHOX.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone age assessment",
            "date": "Not specified",
            "findings": "Bone age was 12 years, in agreement with pubertal status.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "GH (Growth Hormone) levels testing",
            "date": "Not specified",
            "findings": "Low spontaneous GH secretion of 1.6 ng/mL (B) and 2.7 ng/mL (G) with maximum peaks 4.3 ng/mL (B) and 9.2 ng/mL (G).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Arginine infusion stimulation test",
            "date": "Not specified",
            "findings": "GH peak serum levels of 5.3 ng/mL in the boy and 10.0 ng/mL in the girl.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Serum analysis for IGF-I and IGFBP-3",
            "date": "Not specified",
            "findings": "Normal IGF-I and IGFBP-3 serum levels in both children: 62 ng/mL and 2713 ng/mL (B) and 110 ng/mL and 2449 ng/mL (G).",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Height assessment during rhGH treatment",
            "date": "Not specified",
            "findings": "Height increased from -3.5 SD to -2.5 SD (G) and from -2.5 SD to -1.6 SD (B) over 12 months.",
            "changes_over_time": "Height velocity increased from -2.3 SD to -1.9 SD (9.5 cm/yr) (G) and from -2.0 SD to -1.4 SD (9.4 cm/yr) (B)."
        }
    ]
}